Sibling pairs with schizophrenia or schizoaffective disorder: associations of subtypes, symptoms and demographic variables

被引:30
|
作者
Cardno, AG
Jones, LA
Murphy, KC
Sanders, RD
Asherson, P
Owen, MJ
McGuffin, P
机构
[1] Univ Wales Coll Cardiff, Coll Med, Dept Psychol Med, Cardiff CF4 4XN, S Glam, Wales
[2] Univ Wales Coll Cardiff, Coll Med, Dept Med Genet, Cardiff CF1 3NS, S Glam, Wales
[3] Inst Psychiat, London, England
关键词
D O I
10.1017/S0033291798006783
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. Affected sibling pairs provide a valuable means of investigating the familial basis of clinical heterogeneity in schizophrenia. Methods. Associations of schizophrenia subtypes, psychotic symptoms (defined by SAPS/SANS and OPCRIT), affective episodes and demographic variables were studied in 109 sibling pairs with DSM-IV schizophrenia or schizoaffective disorder. Results. None of the subtypes or affective episodes were significantly associated within pairs. A broad definition of positive formal thought disorder, grandiose delusions and delusions of influence (all from OPCRIT) were modestly associated. There was no excess of same-sex pairs. There were modest associations for age of illness onset, pre-morbid adjustment and illness severity. Caution is required in interpreting the results because many statistical tests were carried out. Conclusions. None of the variables appears to be closely associated with specific genetic or shared environmental factors that contribute liability to schizophrenia. They are at best only weakly associated with such factors, and/or are associated with factors unrelated to the aetiology of schizophrenia.
引用
收藏
页码:815 / 823
页数:9
相关论文
共 50 条
  • [31] Use of Natural Language Processing to identify Obsessive Compulsive Symptoms in patients with schizophrenia, schizoaffective disorder or bipolar disorder
    David Chandran
    Deborah Ahn Robbins
    Chin-Kuo Chang
    Hitesh Shetty
    Jyoti Sanyal
    Johnny Downs
    Marcella Fok
    Michael Ball
    Richard Jackson
    Robert Stewart
    Hannah Cohen
    Jentien M. Vermeulen
    Frederike Schirmbeck
    Lieuwe de Haan
    Richard Hayes
    Scientific Reports, 9
  • [32] A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder
    Takeuchi, Hiroyoshi
    Remington, Gary
    PSYCHOPHARMACOLOGY, 2013, 228 (02) : 175 - 185
  • [33] A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder
    Hiroyoshi Takeuchi
    Gary Remington
    Psychopharmacology, 2013, 228 : 175 - 185
  • [34] Greater depressive symptoms are associated with worse functional outcomes in patients diagnosed with schizophrenia or schizoaffective disorder
    Phillips, GA
    Ascher-Svanum, H
    Chen, L
    Kinon, B
    VALUE IN HEALTH, 2005, 8 (03) : 404 - 404
  • [35] Greater depressive symptoms are associated with worse functional outcomes in patients diagnosed with schizophrenia or schizoaffective disorder
    Phillips, GA
    Ascher-Svanum, H
    Chen, L
    Kinon, BJ
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 45S - 45S
  • [36] Exploring negative symptoms heterogeneity in patients diagnosed with schizophrenia and schizoaffective disorder using cluster analysis
    Fekih-Romdhane, Feten
    Hajje, Romy
    Haddad, Chadia
    Hallit, Souheil
    Azar, Jocelyne
    BMC PSYCHIATRY, 2023, 23 (01)
  • [37] Identification of clinically meaningful relationships among cognition, functionality, and symptoms in subjects with schizophrenia or schizoaffective disorder
    Pandina, Gahan
    Bilder, Robert
    Turkoz, Ibrahim
    Alphs, Larry
    SCHIZOPHRENIA RESEARCH, 2013, 143 (2-3) : 312 - 318
  • [38] Exploring negative symptoms heterogeneity in patients diagnosed with schizophrenia and schizoaffective disorder using cluster analysis
    Feten Fekih-Romdhane
    Romy Hajje
    Chadia Haddad
    Souheil Hallit
    Jocelyne Azar
    BMC Psychiatry, 23
  • [39] Anxiety symptoms and quality of life in middle-aged and older outpatients with schizophrenia and schizoaffective disorder
    Wetherell, JL
    Palmer, BW
    Thorp, SR
    Patterson, TL
    Golshan, S
    Jeste, DV
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (12) : 1476 - 1482
  • [40] The long-term benefit of risperidone versus haloperidol for affective symptoms in schizophrenia and schizoaffective disorder
    Myers, J
    Mahmoud, R
    Keith, SJ
    Csernansky, JG
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 240 - 240